Hydroxyurea-SAGO® Capsules USP 500 mg

Oral cytotoxic capsule for hematological and oncological conditions.
Request Information
Description

Description

Hydroxyurea-SAGO® is an orally administered antimetabolite that inhibits ribonucleotide reductase, reducing DNA synthesis in rapidly dividing cells. The product is commonly used in long-term management of hematological disorders and selected malignancies.
Manufactured according to pharmaceutical quality standards, it is supplied for controlled medical use with appropriate patient monitoring.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Hydroxyurea-SAGO® Capsules USP 500 mg”

Your email address will not be published. Required fields are marked *


About brand

Parturient ut id tellus vulputatre ac ultrlices a part ouriesnt sapien dignissim partu rient a a inter drum vehicula. Ornare metus laoreet tincidunt eros rolem tristique pretium malada.

Cras rhoncus vivamus luctus platea arcu laoreet selm. Curae est condenectus sed hac a parturient vestibulum.

Used For
  • Chronic myeloid leukemia

  • Sickle cell disease

  • Myeloproliferative disorders

  • Certain solid tumors